Literature DB >> 16634030

Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study.

Shannon K McDonnell1, Daniel J Schaid, Alexis Elbaz, Kari J Strain, James H Bower, J Eric Ahlskog, Demetrius M Maraganore, Walter A Rocca.   

Abstract

OBJECTIVE: To conduct complex segregation analyses of Parkinson's disease (PD).
METHODS: Data on the familial aggregation of PD remain conflicting. We conducted a historical cohort study of 1,234 relatives of 162 patients with PD representative of people of Olmsted County, MN, and of 3,009 relatives of 411 patients with PD referred to the Mayo Clinic. Relatives were interviewed and screened for parkinsonism either directly or through a proxy, those who screened positive were examined, or a copy of their medical record was obtained to confirm the diagnosis. For subjects who resided in Olmsted County, additional information was obtained from the archives of the Olmsted County Historical Society and from a records-linkage system.
RESULTS: Thirty-two relatives of population-based probands and 69 relatives of referral patients developed PD (101 in total). Combining population-based and referral samples, the model that best explained the familial clustering of PD overall was a major gene with additive effect on the penetrance. This model predicted an average decrease in age at onset of PD of approximately 18 years for each copy of the putative high-risk allele. The best fitting model for younger onset PD (age <or= 59 years) was an autosomal recessive model. The best fitting models for older onset PD (age > 59 years) were a recessive or an additive model.
INTERPRETATION: The familial aggregation of PD may be explained in part by a major gene with additive effect on the penetrance.

Entities:  

Mesh:

Year:  2006        PMID: 16634030     DOI: 10.1002/ana.20844

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

1.  Familial risks of hospitalization for Parkinson's disease in first-degree relatives: a nationwide follow-up study from Sweden.

Authors:  Kristina Sundquist; Xinjun Li; Kari Hemminki
Journal:  Neurogenetics       Date:  2006-08-30       Impact factor: 2.660

2.  The heritability of risk and age at onset of Parkinson's disease after accounting for known genetic risk factors.

Authors:  Taye H Hamza; Haydeh Payami
Journal:  J Hum Genet       Date:  2010-03-05       Impact factor: 3.172

Review 3.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

Review 4.  Genetics of Parkinson disease and essential tremor.

Authors:  Christian Wider; Owen A Ross; Zbigniew K Wszolek
Journal:  Curr Opin Neurol       Date:  2010-08       Impact factor: 5.710

5.  Vitamin D receptor gene as a candidate gene for Parkinson disease.

Authors:  Megan W Butler; Amber Burt; Todd L Edwards; Stephan Zuchner; William K Scott; Eden R Martin; Jeffery M Vance; Liyong Wang
Journal:  Ann Hum Genet       Date:  2011-03       Impact factor: 1.670

6.  Whole-Exome Sequencing in Familial Parkinson Disease.

Authors:  Janice L Farlow; Laurie A Robak; Kurt Hetrick; Kevin Bowling; Eric Boerwinkle; Zeynep H Coban-Akdemir; Tomasz Gambin; Richard A Gibbs; Shen Gu; Preti Jain; Joseph Jankovic; Shalini Jhangiani; Kaveeta Kaw; Dongbing Lai; Hai Lin; Hua Ling; Yunlong Liu; James R Lupski; Donna Muzny; Paula Porter; Elizabeth Pugh; Janson White; Kimberly Doheny; Richard M Myers; Joshua M Shulman; Tatiana Foroud
Journal:  JAMA Neurol       Date:  2016-01       Impact factor: 18.302

7.  Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.

Authors:  Carolina Perez-Pastene; Stephanie A Cobb; Fernando Díaz-Grez; Mary M Hulihan; Marcelo Miranda; Pablo Venegas; Osvaldo Trujillo Godoy; Jennifer M Kachergus; Owen A Ross; Luis Layson; Matthew J Farrer; Juan Segura-Aguilar
Journal:  Neurosci Lett       Date:  2007-06-17       Impact factor: 3.046

8.  Identification of Critical Genes and miRNAs Associated with the Development of Parkinson's Disease.

Authors:  Jia Li; Yajuan Sun; Jiajun Chen
Journal:  J Mol Neurosci       Date:  2018-08-06       Impact factor: 3.444

Review 9.  Update on novel familial forms of Parkinson's disease and multiple system atrophy.

Authors:  Shinsuke Fujioka; Kotaro Ogaki; Pawel M Tacik; Ryan J Uitti; Owen A Ross; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

10.  Genomewide association study for onset age in Parkinson disease.

Authors:  Jeanne C Latourelle; Nathan Pankratz; Alexandra Dumitriu; Jemma B Wilk; Stefano Goldwurm; Gianni Pezzoli; Claudio B Mariani; Anita L DeStefano; Cheryl Halter; James F Gusella; William C Nichols; Richard H Myers; Tatiana Foroud
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.